Insurers and drug-industry middlemen are cashing in on the weight-loss drug frenzy

Explosive demand for new weight-loss drugs likely means bigger profits for US health insurers, as spending increases and members live longer.

https://www.businessinsider.com/health-insurers-could-profit-weight-loss-diabetes-drugs-ozempic-wegovy-2023-9